Novavax (NVAX) Interest & Investment Income (2016 - 2021)
Historic Interest & Investment Income for Novavax (NVAX) over the last 13 years, with Q4 2021 value amounting to $303000.0.
- Novavax's Interest & Investment Income rose 11338.03% to $303000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.4 million, marking a year-over-year increase of 3438.42%. This contributed to the annual value of $1.4 million for FY2021, which is 3451.68% up from last year.
- Latest data reveals that Novavax reported Interest & Investment Income of $303000.0 as of Q4 2021, which was up 11338.03% from $330000.0 recorded in Q3 2021.
- Novavax's 5-year Interest & Investment Income high stood at $807000.0 for Q2 2018, and its period low was $140000.0 during Q3 2020.
- For the 5-year period, Novavax's Interest & Investment Income averaged around $425550.0, with its median value being $419000.0 (2017).
- In the last 5 years, Novavax's Interest & Investment Income tumbled by 5906.43% in 2020 and then skyrocketed by 13571.43% in 2021.
- Novavax's Interest & Investment Income (Quarter) stood at $418000.0 in 2017, then soared by 39.71% to $584000.0 in 2018, then plummeted by 52.74% to $276000.0 in 2019, then tumbled by 48.55% to $142000.0 in 2020, then soared by 113.38% to $303000.0 in 2021.
- Its last three reported values are $303000.0 in Q4 2021, $330000.0 for Q3 2021, and $369000.0 during Q2 2021.